1.46 (-%)
As of Oct 31, 2024
Source:
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies for the treatment of patients with cancers that have critical unmet medical need.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | ( 858 ) 434-1113 |
| Industry | manufacturing |
| CEO | James B. Breitmeyer |
| Website | www.oncternal.com |